NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB
Post# of 73
(Total Views: 33)
Posted On: 10/27/2025 4:11:50 PM
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Founder Gareth Sheridan Returns as CEO to Lead Final Development Phase of AVERSA Fentanyl
Nutriband (NASDAQ: NTRB) today announced that company founder Gareth Sheridan has resumed his role as CEO, effective immediately, following a temporary period during which Co-Founder and Chairman Serguei Melnik served in the position. Sheridan will lead the company through its final 2025 development framework toward an expected 2026 NDA filing for AVERSA Fentanyl, the company’s flagship abuse-deterrent opioid patch. AVERSA Fentanyl is designed to deter misuse and accidental exposure, with potential peak annual U.S. sales estimated between $80 million and $200 million. The AVERSA(TM) technology is protected by patents in 46 countries, including the United States, Europe, and Japan.
NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://nnw.fm/NTRB
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
Nutriband (NASDAQ: NTRB) today announced that company founder Gareth Sheridan has resumed his role as CEO, effective immediately, following a temporary period during which Co-Founder and Chairman Serguei Melnik served in the position. Sheridan will lead the company through its final 2025 development framework toward an expected 2026 NDA filing for AVERSA Fentanyl, the company’s flagship abuse-deterrent opioid patch. AVERSA Fentanyl is designed to deter misuse and accidental exposure, with potential peak annual U.S. sales estimated between $80 million and $200 million. The AVERSA(TM) technology is protected by patents in 46 countries, including the United States, Europe, and Japan.
NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://nnw.fm/NTRB
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)